These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 488666)
1. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats. Priego JG; Maroto ML; Piña M; Catalán RE Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666 [No Abstract] [Full Text] [Related]
2. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats. Priego JG; Maroto ML; Piña M; Catalan RE Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961 [No Abstract] [Full Text] [Related]
3. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action]. Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756 [No Abstract] [Full Text] [Related]
4. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver]. Priego JG; Maroto ML; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397 [No Abstract] [Full Text] [Related]
5. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)]. Kaffarnik H; Schneider J; Haase W Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303 [TBL] [Abstract][Full Text] [Related]
6. Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats. Catalán RE; Aragones MD; Martinez AM; Armijo M; Priego JG Gen Pharmacol; 1979; 10(6):455-8. PubMed ID: 230120 [No Abstract] [Full Text] [Related]
7. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats]. Maroto ML; Priego JG; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396 [No Abstract] [Full Text] [Related]
8. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia]. Sterner W; Schultz A Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360 [No Abstract] [Full Text] [Related]
9. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Kissebah AH; Adams PW; Harrigan P; Wynn V Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694 [No Abstract] [Full Text] [Related]
10. Influence of Etofibrate on plasma fibrinogen and plasminogen concentrations in patients with different forms of primary hyperlipoproteinemia. Spöttl F; Froschauer J Atherosclerosis; 1976; 25(2-3):293-301. PubMed ID: 1008913 [TBL] [Abstract][Full Text] [Related]
11. Effects of etofibrate on platelet function: in vitro studies in human plasma. Ortega MP; Sunkel C; Armijo M; Priego JG Thromb Res; 1980 Aug; 19(3):409-16. PubMed ID: 7001672 [No Abstract] [Full Text] [Related]
13. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism]. Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats. Cayen MN; Robinson WT; Dubuc J; Dvornik D Biochem Pharmacol; 1979 Apr; 28(7):1163-7. PubMed ID: 444274 [No Abstract] [Full Text] [Related]
15. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism. Herrera E; Lasunción MA; Castro M; Gómez-Coronado D; Martín A; Quack G Biochim Biophys Acta; 1988 Nov; 963(1):42-52. PubMed ID: 3179329 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of drugs affecting lipid metabolism]. Rossini L Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137 [No Abstract] [Full Text] [Related]
17. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone. Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152 [TBL] [Abstract][Full Text] [Related]
18. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol. Vessby B; Lithell H; Gustafsson IB; Boberg J Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377 [TBL] [Abstract][Full Text] [Related]
19. Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats. Segal P; Roheim PS; Eder HA J Clin Invest; 1972 Jul; 51(7):1632-8. PubMed ID: 4338117 [TBL] [Abstract][Full Text] [Related]
20. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets. Brattsand R Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017 [No Abstract] [Full Text] [Related] [Next] [New Search]